Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/jcm9061683 http://scihub22266oqcxt.onion/10.3390/jcm9061683 32498230!7356537!32498230     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Med 2020 ; 9 (6): ä Nephropedia Template TP {{tp|p=32498230|t=2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties |pdf=|usr=}}{{32498230}} gab.com Text Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties JO: J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32498230 #FOAvip Since an association between myocardial infarction (MI) and respiratory infections has been described for influenza viruses and other respiratory viral agents, understanding possible physiopathological links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is of the greatest importance. The initial data suggest an underestimation of ACS cases all over the world, but acute MI still represents a major cause of morbidity and mortality worldwide and should not be overshadowed during the coronavirus disease (Covid-19) pandemic. No common consensus regarding the most adequate healthcare management policy for ACS is currently available. Indeed, important differences have been reported between the measures employed to treat ACS in China during the first disease outbreak and what currently represents clinical practice across Europe and the USA. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid-19; epidemiological data related to ACS at the time of the Covid-19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order to shed some light on the current strategies for optimal management of ACS patients with confirmed or suspected SARS-CoV-2 infection. Twit Text FOAVip Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties ????J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32498230 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32498230 #FOAvip English Wikipedia <ref>{{Cite pmid|32498230}}</ref> Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties #MMPMID32498230 Schiavone M; Gobbi C; Biondi-Zoccai G; D'Ascenzo F; Palazzuoli A; Gasperetti A; Mitacchione G; Viecca M; Galli M; Fedele F; Mancone M; Forleo GB J Clin Med 2020[Jun]; 9 (6): ä PMID32498230show ga Since an association between myocardial infarction (MI) and respiratory infections has been described for influenza viruses and other respiratory viral agents, understanding possible physiopathological links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is of the greatest importance. The initial data suggest an underestimation of ACS cases all over the world, but acute MI still represents a major cause of morbidity and mortality worldwide and should not be overshadowed during the coronavirus disease (Covid-19) pandemic. No common consensus regarding the most adequate healthcare management policy for ACS is currently available. Indeed, important differences have been reported between the measures employed to treat ACS in China during the first disease outbreak and what currently represents clinical practice across Europe and the USA. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid-19; epidemiological data related to ACS at the time of the Covid-19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order to shed some light on the current strategies for optimal management of ACS patients with confirmed or suspected SARS-CoV-2 infection. äAcute Coronary Syndromes and Covid-19: Exploring the Uncertainties (epmc).pdf DeepDyve Pubget Overpricing